Page 27 - Vaccine

Oxford University Covid-19 vaccine trial has 50% chance of 'no result'

The University of Oxford last week announced that the advance human trial of the vaccine will involve up to 10,260 volunteers across the UK

4 Covid-19 vaccines may soon enter the clinical-trial stage: Harsh Vardhan

There are over 100 candidate vaccines which are at different levels of development

Polio and measles could surge after disruption of vaccine programs

The problem of slipping vaccine rates is not limited to developing countries

Record jump in Covid-19 cases as tally crosses 125,000; 1st case in Sikkim

Active cases rose to 69,597, while 51,783 people have recovered and a patient has migrated, according to the ministry bulletin

Coronavirus Vaccine Shows Promising Early Results in China

The early-stage trial, published in the Lancet, was conducted by researchers at several laboratories and included 108 participants aged 18 to 60

US plans massive Covid-19 vaccine testing effort to meet year-end deadline

To get there, leading vaccine makers have agreed to share data and lend the use of their clinical trial networks to competitors should their own candidate fail, the scientists said

First Covid-19 vaccine to reach phase-1 trial is safe, say researchers

Several teams across the world are in a race to develop a vaccine for coronavirus infection

Oxford University's Covid-19 vaccine moves to next stage of human trials

The first phase of the trial began last month with 1,000 healthy adults aged 55 and under as volunteers.

US secures 300 million doses of potential AstraZeneca Covid-19 vaccine

Vaccines are seen by world leaders as the only real way to restart their stalled economies.

Oxford University's candidate for coronavirus vaccine fails animal tests

The vaccine's failure to prevent the virus from attacking the rhesus macaque is a setback and kills the hope of treating humans

Bharat Biotech working on Covid-19 vaccine using dormant rabies inoculation

Ties up with Thomas Jefferson University to develop a vaccine candidate that showed a strong antibody response in mice

AstraZeneca says data from Covid-19 vaccine's phase-1 trials to be out soon

Once the late stage trials begin, the company simultaneously will start working on the global manufacturing capabilities.

Moderna's Covid-19 vaccine shows early promise; shares soar around 20%

The data are from eight people who took part in a safety trial that kicked off in March as the global pandemic caused by the novel coronavirus was spreading.

Wall Street surges on hopes for stimulus, Covid-19 vaccine; Dow rises 3.2%

Investors have kept a close eye on vaccine programs of several drugmakers, cheering any positive development amid fears of a second wave of infections as governments start easing restrictions

Great social divide: A new normal post Covid-19

Economic and social activities will come out from slumber in the coming weeks

Important for nations to work together to eradicate Covid-19: Modi to Trump

"I am proud to announce that the United States will donate ventilators to our friends in India. We stand with India and @narendramodi during this pandemic," Trump had said

Coronavirus vaccine not coming for at least 2 years: Novartis global CEO

A vaccine must be widely tested in humans before being administered to hundreds of millions, say experts

Top headlines: Govt to set up Rs 1-trn agri infra fund, job cuts at Zomato

Business Standard brings to you the top headlines of the day

Lockdown serves domestic pharma the bitter pill: April growth slips

Lack of fresh prescriptions drags growth in acute therapies

Pfizer to outsource some drug production, focus on coronavirus vaccine

Pfizer and German partner BioNTech SE (22UAy.F) said on Tuesday they have begun delivering doses of their coronavirus vaccine candidates for initial human testing in the United States.